Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social support.

Saved in:
Bibliographic Details
Title: Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social support.
Authors: Brown, Ryan1 (AUTHOR), Smith, Katie E.2 (AUTHOR), Shanshal, Mohamed M.2 (AUTHOR), Dimou, Anastasios2 (AUTHOR), Leventakos, Konstantinos2 (AUTHOR), Parikh, Kaushal2 (AUTHOR), Mansfield, Aaron S.2 (AUTHOR), Molina, Julian R.2 (AUTHOR), Goetz, Matthew P.2 (AUTHOR), Jatoi, Aminah2 (AUTHOR) jatoi.aminah@mayo.edu, Cathcart-Rake, Elizabeth2 (AUTHOR)
Source: Supportive Care in Cancer. Dec2025, Vol. 33 Issue 12, p1-9. 9p.
Database: Academic Search Ultimate
Description
ISSN:09414355
DOI:10.1007/s00520-025-10182-9